Related Experiment Video

Updated: Jun 6, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.7K

Sobrerol in Managing Acute Respiratory Infections in Clinical Practice During the "Cold" Season: An Italian Primary

Attilio Varricchio1, Giorgio Ciprandi2,

  • 1Department of Otolaryngology, University of Molise, Campobasso, Italy.

International Journal of General Medicine
|November 29, 2024
PubMed
Abstract

Insights

Combined oral and nebulized sobrerol effectively reduced symptoms and accelerated recovery in acute upper respiratory infections (AURI). This mucolytic agent offers a valuable add-on treatment for AURI patients.

Area of Science:

  • Respiratory Medicine
  • Pharmacology

Background:

  • Acute upper respiratory infections (AURI) are common in primary care.
  • Mucus production is a significant symptom impairing patients during AURI.
  • Sobrerol is a muco-active agent with potential benefits for AURI management.

Purpose of the Study:

  • To compare the efficacy and safety of different sobrerol administration methods in AURI patients.
  • Investigate sobrerol as an add-on therapy to standard infection treatment.
  • Evaluate oral, nebulized, and combined sobrerol use.

Main Methods:

  • Retrospective case-series study involving ten primary care physicians.
  • Collected clinical data from patients with AURI over an extended period.
  • Patients received standard infection therapy with or without oral sobrerol, nebulized sobrerol, or combined therapy for 3 days.

Main Results:

  • Combined oral and nebulized sobrerol significantly reduced symptom intensity, particularly cough and nasal complaints.
  • Patients on combined therapy experienced faster resolution of cough and nasal symptoms by day 7.
  • The combined approach showed a statistically significant improvement compared to other methods.

Conclusions:

  • A three-day course of combined oral and nebulized sobrerol is a valuable add-on treatment for AURI.
  • This approach effectively manages mucus production and associated symptoms.
  • Sobrerol demonstrates a favorable safety and efficacy profile in AURI management.
Keywords:
acute upper respiratory infectionscombined therapynebulizationoral formulationprimary caresobrerol

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K
Remote Laboratory Management: Respiratory Virus Diagnostics14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.1K

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
310
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
173